期刊文献+

高龄多囊卵巢综合征患者的卵巢储备特点及其助孕结局 被引量:14

Features of ovarian reserve and outcomes of assisted reproductive technology in elder patients with PCOS
原文传递
导出
摘要 35岁后多囊卵巢综合征(PCOS)患者的卵巢储备较之同龄人可能有一定的优势。在行辅助生育技术(ART)过程中,40岁前的获卵数往往高于同龄非PCOS人群,40岁以后PCOS患者同样有卵泡质量及胚胎发育潜能不足的问题,对ART助孕结局产生不利影响。现有资料表明,PCOS患者在40岁以后的临床妊娠率、活产率与同龄非PCOS人群的变化趋势一样,同时其代谢、内分泌因素对妊娠结局的负面影响仍然存在。 Patients with polycystic ovary syndrome( PCOS) older than 35 yrs may possess a potential advantage of ovarian reserve compared with women of the same age. When assisted reproductive technology( ART) is performed,PCOSpatients younger than 40 yrs usually have more retrieved oocytes than age-matched non-PCOS infertile patients. Nevertheless,age related decline in the quality of follicles and deficiency in fetal development adversely affect the outcomes of ART in PCOS patients thereafter. Data showthat PCOS patients have the same tendency of age-related decline in terms of clinical pregnancy rate and live birth rate,as with non-PCOS population of the same age,while metabolic and endocrine factors unfavorably influence pregnancy outcomes.
作者 杨冬梓 麦卓瑶 YANG Dongzi MAI Zhuoyao(Department of Obstetrics and Gynecology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, Guangdong, China)
出处 《山东大学学报(医学版)》 CAS 北大核心 2017年第1期26-32,共7页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金(81370680) 广东省自然基金重点项目(2013020012660) 广州市科技项目(2014YZ-00512) 中山大学5010项目(2014005)
关键词 高龄 多囊卵巢综合征 辅助生殖技术 妊娠结局 Ageing Polycystic ovary syndrome Assisted reproductive technology Outcome
  • 相关文献

参考文献2

二级参考文献59

  • 1陈子江,李媛,赵力新,姜晶晶,唐蓉,盛燕,高芹,张中和.超声下未成熟卵泡抽吸术治疗多囊卵巢综合征不孕的临床研究[J].中华妇产科杂志,2005,40(5):295-298. 被引量:83
  • 2Gambineri A,Patton L,Vaccina A,et al.Treatment with flutamide,metformin,and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome:a randomized,12-month,placebo-controlled study.J Clin Endocrinol Metab,2006,91:3970-3980.
  • 3Abu Hashim H,Shokeir T,Badawy A.Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome:a randomized controlled trial.Fertil Steril,2010,94:1405-1409.
  • 4Otta CF,Wior M,Iraci GS,et al.Clinical,metabolic,and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome:a randomized,double-blind,and placebo control trial.Gynecol Endocrinol,2010,26:173-178.
  • 5Kazerooni T,Shojaei-Baghini A,Dehbashi S,et al.Effects of mefformin plus simvastatin on polycystic ovary syndrome:a prospective,randomized,double-blind,placebo-controlled study.Fertil Steril,2010,94:2208-2213.
  • 6Ghandi S,Mlatoonian A,Tabibnejad N,et al.The effects of metformin or orlistat on obese women with polycystic ovary syndrome:a prospective randomized open-label study.J Assist Reprod Genet,2011,28:591-596.
  • 7Jedel E,Labrie F,Odén A,et al.lmpact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome:a randomized controlled trial.Am J Physiol Endocrinol Metab,2011,300:37-45.
  • 8Hoeger K,Davidson K,Kochman L,et al.The impact of metformin,oral contraceptives,and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized,placebo-controlled clinical trials.J Clin Endocrinol Metab,2008,93: 4299-4306.
  • 9Moran LJ,Noakes M,Clifton PM,et al.Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome.Am J Clin Nutr,2006,84:77-87.
  • 10Ibánez L,López-Bermejo A,Díaz M,et al.Low-dose pioglitazone and low-dose flutamide added to metformin and oestroprogestagens for hyperinsulinaemic women with androgen excess:add-on benefits disclosed by a randomized double-placebo study over 24 months.Clin Endocrinol(Oxf),2009,71:351-357.

共引文献38

同被引文献127

引证文献14

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部